UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.163-168

2007

Volltextzugriff (PDF)

Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.930-937

2009

Volltextzugriff (PDF)

Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective

Rheumatology (Oxford, England), 2008-02, Vol.47 (2), p.188-193

2008

Volltextzugriff (PDF)

AB0266 Responsiveness and minimal important difference of the rheumatoid arthritis-work instability scale (ra-wis)

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A867-A867

2013

Volltextzugriff (PDF)

SAT0567 Prevalence Estimates of Axial Spondyloarthritis among Patients in German Rheumatology Practices

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A774-A775

2013

Volltextzugriff (PDF)

OP0105 Effect of Adalimumab on Physical Function, Health-Related Quality of Life, and Work Productivity in Patients with Peripheral Spondyloarthritis: Results from the Ability-2 Clinical Trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A86-A86

2013

Volltextzugriff (PDF)

Is Azithromycin the First-Choice Macrolide for Treatment of Community-Acquired Pneumonia?

Clinical infectious diseases, 2004-07, Vol.39 (1), p.144-145

2004

Volltextzugriff (PDF)

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate

Annals of the rheumatic diseases, 2013-07, Vol.72 (7), p.1156-1162

2013

Volltextzugriff (PDF)

Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study

Arthritis care & research (2010), 2010-02, Vol.62 (2), p.226-234

2010

Volltextzugriff (PDF)

Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis

Journal of occupational and environmental medicine, 2013-03, Vol.55 (3), p.240-244

2013

Volltextzugriff (PDF)

SAT0271 Predictors of physical function and mobility in nonradiographic axial spondyloarthritis and ankylosing spondylitis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.563-563

2013

Volltextzugriff (PDF)

FRI0412 Methodological issues when performing mixed treatment comparisons in rheumatoid arthritis: A sensitivity analysis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.453-453

2013

Volltextzugriff (PDF)

FRI0286 Burden of the disease in axial spondyloarthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.410-411

2013

Volltextzugriff (PDF)

FRI0406 Prevalence estimate and gender distribution of axial spondyloarthritis among patients in us rheumatology practices

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.451-452

2013

Volltextzugriff (PDF)

AB1344 Hospital infusion center costs for anti–tumor necrosis factor agents

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.714-714

2013

Volltextzugriff (PDF)

FRI0153 Comparisons of work productivity and patient-reported outcomes through 78 weeks among optima study arms 2, 4, and 5

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.362-363

2013

Volltextzugriff (PDF)

AB0379 Laboratory Safety of Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Rheumatoid Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.931-931

2014

Volltextzugriff (PDF)

SAT0449 Progression from undifferentiated spondyloarthritis to ankylosing spondylitis: Is USPA a proxy for non-radiographic axial SPA?

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.624-624

2013

Volltextzugriff (PDF)

Comments on Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin and Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin or 10 days

Current medical research and opinion, 2004-12, Vol.20 (12), p.1895-1897

Cifaldi, Mary A

2004

Volltextzugriff (PDF)

COMPARISONS OF WORK PRODUCTIVITY AND PATIENT-REPORTED OUTCOMES THROUGH 78 WEEKS AMONG OPTIMA STUDY ARMS 2, 4, AND 5

ANNALS OF THE RHEUMATIC DISEASES, 2013, Vol.71, p.362

2013

Volltextzugriff (PDF)

PIN38: COST-EFFECTIVENESS OF LOPINAVIR/RITONAVIR COMPARED TO NELFINAVIR AS FIRST-LINE ANTIRETROVIRAL THERAPY IN TREATMENTNAÏVE HIV PATIENTS: A MANAGED CARE PERSPECTIVE

Value in health, 2003-05, Vol.6 (3), p.265-265

2003

Volltextzugriff (PDF)

Patient-Reported Outcomes in Early Rheumatoid Arthritis Patients Failing to Achieve Stable Low Disease Activity: Comparing Addition of Adalimumab to Methotrexate Monotherapy with Maintenance On Adalimumab Plus Methotrexate

ARTHRITIS AND RHEUMATISM, 2012, Vol.64 (10), p.S162

2012

Volltextzugriff (PDF)

Differences in Short-Term Radiographic Progression Following Early Response to Adalimumab Plus Methotrexate Vs. Methotrexate Alone

ARTHRITIS AND RHEUMATISM, 2012, Vol.64 (10), p.S160

2012

Volltextzugriff (PDF)

Combination Therapy with Adalimumab plus Methotrexate Significantly Improved Work Ability, Physical Function, Fatigue, and Other Patient-Reported Outcomes in Early Rheumatoid Arthritis: Results From a 26-Week Analysis

ARTHRITIS AND RHEUMATISM, 2011, Vol.63 (10), p.S853

2011

Volltextzugriff (PDF)

ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis

Oncogene, 2013-02, Vol.32 (8), p.998-1009

2013

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(45)
Science & Technology
(39)
Life Sciences & Biomedicine
(38)
Male
(27)
Female
(26)
Adult
(23)
Internal Medicine
(20)
Middle Aged
(19)
Aged
(15)
Medicin Och Hälsovetenskap
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(13)
Rheumatology
(11)
Rheumatoid Arthritis
(9)
Antirheumatic Agents - Therapeutic Use
(8)
Diseases Of The Osteoarticular System
(8)
Inflammatory Joint Diseases
(8)
Pharmacology. Drug Treatments
(8)
Adalimumab
(7)
Arthritis, Rheumatoid - Drug Therapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group

Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective

AB0266 Responsiveness and minimal important difference of the rheumatoid arthritis-work instability scale (ra-wis)

SAT0567 Prevalence Estimates of Axial Spondyloarthritis among Patients in German Rheumatology Practices

OP0105 Effect of Adalimumab on Physical Function, Health-Related Quality of Life, and Work Productivity in Patients with Peripheral Spondyloarthritis: Results from the Ability-2 Clinical Trial

Is Azithromycin the First-Choice Macrolide for Treatment of Community-Acquired Pneumonia?

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate

Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study

Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis

SAT0271 Predictors of physical function and mobility in nonradiographic axial spondyloarthritis and ankylosing spondylitis

FRI0412 Methodological issues when performing mixed treatment comparisons in rheumatoid arthritis: A sensitivity analysis

FRI0286 Burden of the disease in axial spondyloarthritis

FRI0406 Prevalence estimate and gender distribution of axial spondyloarthritis among patients in us rheumatology practices

AB1344 Hospital infusion center costs for anti–tumor necrosis factor agents

FRI0153 Comparisons of work productivity and patient-reported outcomes through 78 weeks among optima study arms 2, 4, and 5

AB0379 Laboratory Safety of Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Rheumatoid Arthritis

SAT0449 Progression from undifferentiated spondyloarthritis to ankylosing spondylitis: Is USPA a proxy for non-radiographic axial SPA?

COMPARISONS OF WORK PRODUCTIVITY AND PATIENT-REPORTED OUTCOMES THROUGH 78 WEEKS AMONG OPTIMA STUDY ARMS 2, 4, AND 5

PIN38: COST-EFFECTIVENESS OF LOPINAVIR/RITONAVIR COMPARED TO NELFINAVIR AS FIRST-LINE ANTIRETROVIRAL THERAPY IN TREATMENTNAÏVE HIV PATIENTS: A MANAGED CARE PERSPECTIVE

Patient-Reported Outcomes in Early Rheumatoid Arthritis Patients Failing to Achieve Stable Low Disease Activity: Comparing Addition of Adalimumab to Methotrexate Monotherapy with Maintenance On Adalimumab Plus Methotrexate

Differences in Short-Term Radiographic Progression Following Early Response to Adalimumab Plus Methotrexate Vs. Methotrexate Alone

Combination Therapy with Adalimumab plus Methotrexate Significantly Improved Work Ability, Physical Function, Fatigue, and Other Patient-Reported Outcomes in Early Rheumatoid Arthritis: Results From a 26-Week Analysis

ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis

Suchergebnisse filtern